MOH Company Profile and Key Details

MOH has shown mixed momentum, gaining 5.2% over the past week and -0.73% over the past quarter, though year-to-date performance is up 10.22%. Short-term trend indicators are bullishly aligned (SMA20 -3.24%, SMA50 -12.79%, SMA200 -24.93%). The stock’s 14-day RSI is 42.86 (neutral), while the ATR of 8.62 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -59.34% below its high and over 20.9% above its low. Average 10-day trading volume of 1.38 million shares is slightly above the 3-month average of 1.12 million, indicating heightened recent market interest.

Molina Healthcare, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.04 thousand. This means the shares are trading below this model’s fair value.

Molina Healthcare, Inc. (NYSE:MOH) shares are up 10.22% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Molina Healthcare, Inc. trading at a premium to the broader market with a P/E of 67.81. Analyst sentiment is cautious, with the majority of ratings in Sector Perform territory and a mean price target of $276.48, suggesting 20.28% upside. Our AI forecast model points to short-term strength (9.04% over two weeks), a medium-term rise (30.14% over three months), and a longer-term loss (-32.33% over one year), with expected trading ranges indicating moderate volatility.

Molina Healthcare, Inc. generated EPS of $8.55 over the past year. Five-year average earnings growth is -4.51%. Wall Street analysts project EPS growth of 17.05% annually over the next five years. The latest quarter delivered EPS of $2.35. The next quarter is forecast at $2.66. Next year's EPS is expected at $13.31. Analyst sentiment is neutral. Analyst rating data shows there are 8 Strong Buy ratings, 1 Buy ratings, 32 Hold ratings, 0 Sell rating and 5 Strong Sell ratings. Price targets range from $335.00 to $144.00. The high target offers 45.73% upside. The low target suggests -37.36% downside. The mean target is $192.24. This offers -16.37% upside. Molina Healthcare, Inc. earnings surprise history is a mixed track record. The quarter that ended April 22, 2026, missed forecasts by 49.68%. The prior quarter beat by -739.53%. Over the last six quarters, Apple has recorded several small beats. These include -12.02% in February 05, 2025.

Our AI price prediction model suggests that Molina Healthcare, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 9.04%, with price expected at $250.66 by July 16, 2026, within a range of $242.91 to $258.86 3-Month Outlook: Projected rise of 30.14%, reaching $299.15 by September 30, 2026, with a range of $267.33 to $322.63. 1-Year Outlook: Projected loss of -32.33%, with price at $155.56 by July 02, 2027, within a range of $136.16 to $176.66.

Molina Healthcare, Inc. has 54.20 million shares outstanding. The public float is 53.50 million shares, elevated short interest at 4.23% of float. This equals 1.75 million shares. The short ratio is 0.84 days. Institutional investors hold 113.49% of the float. Insiders own 1.42%. Zubretsky Joseph M holds 257.72 thousand shares, WOYS JAMES has 69.83 thousand shares and Barlow Jeff D. has 67.18 thousand shares. Over the past six months, insider transactions show net selling. They sold 18.32 thousand shares across 2 transactions.